
Omnipod 5 improves glycaemic levels in people transitioning from daily injections
Individuals with type 1 diabetes (T1D) have demonstrated improvements in glycaemic control after transitioning away from daily insulin injections to Insult’s Omnipod 5 automated insulin delivery device. The open label, single-arm Radiant study (NCT04196140 …